Peritoneal dialysis
Comparison to hemodialysis

The costs of PD are generally lower than those of HD in most parts of the world; this cost advantage is most apparent in high-income countries. There is insufficient research to adequately compare the risks and benefits between CAPD and APD; a Cochrane Review of three small clinical trials found no difference in clinically important outcomes (i.e. morbidity or mortality) for patients with end stage renal disease, nor was there any advantage in preserving the functionality of the kidneys. The results suggested APD may have psychosocial advantages for younger patients and those who are employed or pursuing an education.
detectable_content:postscript